Nanosonics Limited

ASX:NAN ISIN:AU000000NAN9

Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets.<br /><br />Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. In parallel with the commercialisation of this product, Nanosonics is also developing other medical applications and exploring opportunities for its proprietary technology in other industries. 
 
   

查看其它语言版本

新闻

3月30日亚洲市场纵览

🕔3/30/2009 3:00:25 PM 21610

美国股市周五回落后,大多数亚洲股市周一交易日开市十分波动。东京和首尔市场开盘平淡,然后很快进入下跌区域。今天投资者也在等待美国政府公布援助汽车工业的计划。

阅读全文
###

33,516 公司背景浏览

  • 本页浏览人次: (过去7日: 26) (过去30日: 77) (自发布以来: 9040) 

公司详细信息

更多新闻纪录

  • 2024/11/15: Appendix 3Z*
  • 2024/11/15: Appendix 3Z*
  • 2024/11/13: Application for quotation of securities - NAN*
  • 2024/11/13: Notification of cessation of securities - NAN*
  • 2024/11/12: 2024 AGM Results of Meeting*
  • 2024/11/12: 2024 Annual General Meeting Chairman's & CEO's Addresses*
  • 2024/11/12: 2024 Annual General Meeting Presentation*
  • 2024/10/16: Changes to Non-Executive Directors*
  • 2024/10/14: 2024 AGM Notice of Meeting*
  • 2024/10/07: Change in substantial holding from MUFG*
*refer to company website